Differential expression of 2′,3′-cyclic-nucleotide 3′-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival

Clinical Cancer Research

Volumn 18, Issue 13, 2012, Pages 3628-3636

  Zorniak, Michael ^a   Clark, Paul A ^a   Leeper, Heather E ^a   Tipping, Matthew D ^a   Francis, David M ^a   Kozak, Kevin R ^a   Salamat, M Shahriar ^a   Kuo, John S ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CELL MARKER; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER STEM CELL; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL ISOLATION; CELL LINEAGE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOASSAY; IMMUNOBLOTTING; MOLECULAR BIOLOGY; MOUSE; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL LINEAGE; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PHOSPHORIC DIESTER HYDROLASES; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84863306358     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-0339     Document Type: Article

References (47)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96. (Pubitemid 40349501)
2. Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, et al. Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 2006;65:846-54. (Pubitemid 44371230)
3. Linskey ME. Glial ontogeny and glial neoplasia: the search for closure. J Neurooncol 1997;34:5-22. (Pubitemid 27270248)
4. Gravendeel LAM, Kouwenhoven MCM, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 2009;69:9065-72.
5. Kim TM, Huang W, Park R, Park PJ, Johnson MD. A developmental taxonomy of glioblastoma defined and maintained by microRNAs. Cancer Res 2011;71:3387-99.
6. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
7. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006;9:157-73. (Pubitemid 43357943)
8. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403. (Pubitemid 43668737)
9. Esposito C, Scrima M, Carotenuto A, Tedeschi A, Rovero P, D'Errico G, et al. Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2′,3′-cyclic nucleotide-3′- phosphodiesterase. Biochemistry 2008;47:308-19.
10. Trapp BD, Bernier L, Andrews SB, Colman DR. Cellular and subcellular distribution of 2′,3′-cyclic nucleotide 3′-phosphodiesterase and its mRNA in the rat central nervous system. J Neurochem 1988;51: 859-68.
11. Drummond GI, Perrott-Yee S. Enzymatic hydrolysis of adenosine 3′,5′-phosphoric acid. J Biol Chem 1961;236:1126-9.
12. Gravel M, Robert F, Kottis V, Gallouzi IE, Pelletier J, Braun PE. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: a novel RNA-binding protein that inhibits protein synthesis. J Neurosci Res 2009;87:1069-79.
13. Myllykoski M, Raasakka A, Han H, Kursula P. Myelin 20,30-cyclic nucleotide 30-phosphodiesterase: active-site ligand binding and molecular conformation. PLoS One 2012;7:e32336.
14. de Vries H, de Jonge JC, Schrage C, van der Haar ME, Hoekstra D. Differential and cell development-dependent localization of myelin mRNAs in oligodendrocytes. J Neurosci Res 1997;47:479-88. (Pubitemid 27106544)
15. Gobert RP, Joubert L, Curchod ML, Salvat C, Foucault I, Jorand-Lebrun C, et al. Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol 2009;29:1538-53.
16. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8. (Pubitemid 37187480)
17. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, et al. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 1998;85:141-52. (Pubitemid 29003064)
18. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193-206.
19. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009;4:568-80.
20. Clark PA, Treisman DM, Ebben J, Kuo JS. Developmental signaling pathways in brain tumor-derived stem-like cells. Dev Dyn 2007;236:3297-308. (Pubitemid 350276387)
21. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401. (Pubitemid 39551674)
22. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21. (Pubitemid 39331011)
23. Moser FG, Dorman BP, Ruddle FH. Mouse-human heterokaryon analysis with a 33258 Hoechst-Giemsa technique. J Cell Biol 1975;66:676-80.
24. Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, et al. Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clin Cancer Res 2012;18:1464-71.
25. Hu BY, Du ZW, Zhang SC. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 2009;4:1614-22.
26. Central Brain Tumor Registry of the United States [database on the Internet]. Hindsdale (IL): CBTRUS. [cited 2012 Mar 18]. Available from: http://www.cbtrus.org.
27. National Cancer Institute (NCI) Repository for Molecular Brain Neoplasia Data (REMBRANDT) [database on the Internet]. Bethesda (MD): National Cancer Institute. [cited 2011 Dec 21] Available from: http://rembrandt-db.nci.nih.gov.
28. National Cancer Institute (NCI) The Cancer Genome Atlas (TCGA) Cancer Genomics Portal [database on the Internet]. New York (NY): Memorial Sloan-Kettering Cancer Center. [cited 2012 Mar 11] Available from: http://www.cbioportal.org/public-portal/.
29. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003;63:1602-7. (Pubitemid 36373650)
30. TCGA. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-8.
31. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 2003;22:2361-73. (Pubitemid 36566791)
32. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 2005;102:5814-9. (Pubitemid 40559642)
33. Tso CL, Freije WA, Day A, Chen Z, Merriman B, Perlina A, et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res 2006;66:159-67. (Pubitemid 43166021)
34. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010;17:362-75.
35. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008;27:2897-909. (Pubitemid 351620450)
36. Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J, et al. Transcriptional profiles of CD133+ and CD133-glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res 2010;70:2030-40.
37. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, et al. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 2009;4:e7752.
38. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009;138: 822-9.
39. Chaichana K, Zamora-Berridi G, Camara-Quintana J, Quinones-Hinojosa A. Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies. Stem Cells 2006;24: 2851-7. (Pubitemid 46053021)
40. Clark PA, Iida M, Treisman DM, Kalluri H, Ezhilan S, Zorniak M, et al. Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR Targeted Inhibition. Neoplasia 2012;14:420-28.
41. Fine HA. Glioma stem cells: not all created equal. Cancer Cell 2009;15:247-9.
42. Parker KK, Norenberg MD, Vernadakis A. "Transdifferentiation" of C6 glial cells in culture. Science 1980;208:179-81.
43. Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene 2009;28:2266-75.
44. Hinman JD, Chen CD, Oh SY, Hollander W, Abraham CR. Age-dependent accumulation of ubiquitinated 2′,3′-cyclic nucleotide 3′-phosphodiesterase in myelin lipid rafts. Glia 2008;56:118-33. (Pubitemid 350172737)
45. Pinto LW, Araujo MB, Vettore AL, Wernersbach L, Leite AC, Chimelli LM, et al. Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch 2008;452:481-90.
46. Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H, et al. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 2011;146:209-21.
47. Mangiola A, de Bonis P, Maira G, Balducci M, Sica G, Lama G, et al. Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer 2008;113:841-6.